Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Enfortumab Vedotin/Enfortumab vedotin-ejfv & Bladder cancer, Enfortumab Vedotin/Enfortumab vedotin-ejfv is approved by both the FDA and EMA for the treatment of advanced Bladder cancer (1)
Enfortumab vedotin-ejfv / Enfortumab Vedotin has changed the standard of care treatment in Bladder cancer with a high response and disease-control rate, acceptable toxicity profile and improved overall survival…